Gruppo Italiano Malattie Ematologiche Dell'adulto
Clinical trials sponsored by Gruppo Italiano Malattie Ematologiche Dell'adulto, explained in plain language.
-
New drug study aims to shrink enlarged spleens in blood disorder patients
Disease control Not yet recruitingThis study observes how well the drug momelotinib works for people with myelofibrosis, a serious bone marrow disorder, in real-world medical settings. Researchers will follow 93 adult patients who have an enlarged spleen to see if the treatment reduces spleen size by at least hal…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New test could spot hidden leukemia mutations sooner
Diagnosis Not yet recruitingThis study aims to see if a new, highly sensitive blood test (called digital PCR) is as good as the current standard test (NGS) at finding specific mutations that make chronic myeloid leukemia (CML) resistant to certain drugs. It will involve 150 adult CML patients whose current …
Phase: NA • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
Doctors review past cases to gauge leukemia Drug's Real-World impact
Knowledge-focused Not yet recruitingThis study looks back at the medical records of about 100 adults with a specific type of leukemia (Philadelphia-positive ALL) who were already treated with the drug ponatinib as part of their regular care. The goal is to see how effective the treatment was in a real-world setting…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC